2004
DOI: 10.1590/s1415-47572004000300001
|View full text |Cite
|
Sign up to set email alerts
|

Animal models for human contiguous gene syndromes and other genomic disorders

Abstract: Genomic disorders refer to a group of syndromes caused by DNA rearrangements, such as deletions and duplications, which result in an alteration of normal gene dosage. The chromosomal rearrangements are usually relatively small and often difficult to detect cytogenetically. In a subset of such conditions the rearrangements comprise multiple unrelated contiguous genes that are physically linked and thus have been referred to as contiguous gene syndromes (CGS). In general, each syndrome presents a complex clinica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 133 publications
(132 reference statements)
0
5
0
Order By: Relevance
“…For example, dosage effects of gene duplications or deletions underlie dozens of human disease disorders (Lupski 1998), with phenotypic effects ranging from mental retardation to infertility (Shaw and Lupski 2004; Lupski and Stankiewicz 2006; Conrad and Antonarakis 2007). A rapidly growing literature in human medical genetics is focused on gene copy number variants (CNVs) as causes of disease (Lupski and Stankiewicz 2006); similar effects are seen in mouse (Inoue and Lupski 2002; Walz et al 2004). Because these data have emerged primarily from disease studies, it is unknown how pervasive gene‐specific dosage effects are across the entire genome.…”
Section: Gene Movement and The Large X‐effect: Empirical Supportmentioning
confidence: 99%
“…For example, dosage effects of gene duplications or deletions underlie dozens of human disease disorders (Lupski 1998), with phenotypic effects ranging from mental retardation to infertility (Shaw and Lupski 2004; Lupski and Stankiewicz 2006; Conrad and Antonarakis 2007). A rapidly growing literature in human medical genetics is focused on gene copy number variants (CNVs) as causes of disease (Lupski and Stankiewicz 2006); similar effects are seen in mouse (Inoue and Lupski 2002; Walz et al 2004). Because these data have emerged primarily from disease studies, it is unknown how pervasive gene‐specific dosage effects are across the entire genome.…”
Section: Gene Movement and The Large X‐effect: Empirical Supportmentioning
confidence: 99%
“…However, establishing a correlation between each phenotypic feature and the particular dosage-sensitive gene has often been a major challenge due to the usually large number of genes mapping within or around the rearranged genomic interval. Murine models have proven to be extremely valuable for the identification of the predominant responsible gene(s) (10).…”
Section: Introductionmentioning
confidence: 99%
“…To examine this hypothesis further, chromosome-engineered animal models of SoS deletion may be useful. 47 These experiments, along with further studies of the genomic region deleted in SoS patients, are likely to promote further insights into the specific genes that contribute to the clinical phenotype of SoS.…”
Section: Phenotypic Consequences Of Genetic Variation At Hemizygous Amentioning
confidence: 99%